BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22916154)

  • 21. Expression of the p53 Inhibitors MDM2 and MDM4 as Outcome Predictor in Muscle-invasive Bladder Cancer.
    Kriegmair MC; Balk M; Wirtz R; Steidler A; Weis CA; Breyer J; Hartmann A; Bolenz C; Erben P
    Anticancer Res; 2016 Oct; 36(10):5205-5213. PubMed ID: 27798881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2/MDM4 dual inhibitor.
    Eskandari M; Shi Y; Liu J; Albanese J; Goel S; Verma A; Wang Y
    Leuk Lymphoma; 2021 Jan; 62(1):167-175. PubMed ID: 32924682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma.
    Jacob AG; O'Brien D; Singh RK; Comiskey DF; Littleton RM; Mohammad F; Gladman JT; Widmann MC; Jeyaraj SC; Bolinger C; Anderson JR; Barkauskas DA; Boris-Lawrie K; Chandler DS
    Neoplasia; 2013 Sep; 15(9):1049-63. PubMed ID: 24027430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
    Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
    Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-resolution array-based comparative genomic hybridization of bladder cancers identifies mouse double minute 4 (MDM4) as an amplification target exclusive of MDM2 and TP53.
    Veerakumarasivam A; Scott HE; Chin SF; Warren A; Wallard MJ; Grimmer D; Ichimura K; Caldas C; Collins VP; Neal DE; Kelly JD
    Clin Cancer Res; 2008 May; 14(9):2527-34. PubMed ID: 18451213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases.
    Leventaki V; Rodic V; Tripp SR; Bayerl MG; Perkins SL; Barnette P; Schiffman JD; Miles RR
    Br J Haematol; 2012 Sep; 158(6):763-71. PubMed ID: 22845047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.
    Fang S; Krahe R; Lozano G; Han Y; Chen W; Post SM; Zhang B; Wilson CD; Bachinski LL; Strong LC; Amos CI
    PLoS One; 2010 May; 5(5):e10813. PubMed ID: 20520810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomas.
    Valentin-Vega YA; Barboza JA; Chau GP; El-Naggar AK; Lozano G
    Hum Pathol; 2007 Oct; 38(10):1553-62. PubMed ID: 17651783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDM2 as a modifier gene in retinoblastoma.
    Castéra L; Sabbagh A; Dehainault C; Michaux D; Mansuet-Lupo A; Patillon B; Lamar E; Aerts I; Lumbroso-Le Rouic L; Couturier J; Stoppa-Lyonnet D; Gauthier-Villars M; Houdayer C
    J Natl Cancer Inst; 2010 Dec; 102(23):1805-8. PubMed ID: 21051655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of the p53 pathway in retinoblastoma.
    Laurie NA; Donovan SL; Shih CS; Zhang J; Mills N; Fuller C; Teunisse A; Lam S; Ramos Y; Mohan A; Johnson D; Wilson M; Rodriguez-Galindo C; Quarto M; Francoz S; Mendrysa SM; Guy RK; Marine JC; Jochemsen AG; Dyer MA
    Nature; 2006 Nov; 444(7115):61-6. PubMed ID: 17080083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the Association between MDM4 rs4245739 Single Nucleotide Polymorphism and Breast Cancer Susceptibility.
    Pedram N; Pouladi N; Feizi MA; Montazeri V; Sakhinia E; Estiar MA
    Clin Lab; 2016 Jul; 62(7):1303-1308. PubMed ID: 28164646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MDM4 (MDMX) overexpression enhances stabilization of stress-induced p53 and promotes apoptosis.
    Mancini F; Gentiletti F; D'Angelo M; Giglio S; Nanni S; D'Angelo C; Farsetti A; Citro G; Sacchi A; Pontecorvi A; Moretti F
    J Biol Chem; 2004 Feb; 279(9):8169-80. PubMed ID: 14660608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in development.
    Steinman HA; Hoover KM; Keeler ML; Sands AT; Jones SN
    Oncogene; 2005 Nov; 24(53):7935-40. PubMed ID: 16027727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The MDM2 gene family.
    Mendoza M; Mandani G; Momand J
    Biomol Concepts; 2014 Mar; 5(1):9-19. PubMed ID: 25372739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.
    Gansmo LB; Bjørnslett M; Halle MK; Salvesen HB; Dørum A; Birkeland E; Hveem K; Romundstad P; Vatten L; Lønning PE; Knappskog S
    Tumour Biol; 2016 Aug; 37(8):10697-702. PubMed ID: 26867771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the p53 pathway in peripheral blood of retinoblastoma patients; potential biomarkers.
    Martínez-Sánchez M; Moctezuma-Dávila M; Hernandez-Monge J; Rangel-Charqueño M; Olivares-Illana V
    PLoS One; 2020; 15(6):e0234337. PubMed ID: 32502182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification.
    Riemenschneider MJ; Büschges R; Wolter M; Reifenberger J; Boström J; Kraus JA; Schlegel U; Reifenberger G
    Cancer Res; 1999 Dec; 59(24):6091-6. PubMed ID: 10626796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic functions of hMDMX in in vitro transformation of primary human fibroblasts and embryonic retinoblasts.
    Lenos K; de Lange J; Teunisse AF; Lodder K; Verlaan-de Vries M; Wiercinska E; van der Burg MJ; Szuhai K; Jochemsen AG
    Mol Cancer; 2011 Sep; 10():111. PubMed ID: 21910853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection.
    Yang H; Zheng Z; Zhao LY; Li Q; Liao D
    Cell Cycle; 2012 Feb; 11(3):582-93. PubMed ID: 22262167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.
    Toledo F; Krummel KA; Lee CJ; Liu CW; Rodewald LW; Tang M; Wahl GM
    Cancer Cell; 2006 Apr; 9(4):273-85. PubMed ID: 16616333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.